New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

NYU-Poly Nanoscientists Reach the Holy Grail in Label-Free Cancer Marker Detection: Single Molecules

September 17, 2013

Researchers at NYU-Poly used a nano-enhanced version of their patented microcavity biosensor to detect a single cancer marker protein, which is one-sixth the size of the smallest virus, and even smaller molecules below the mass of all known markers.

This achievement shatters the previous record, setting a new benchmark for the most sensitive limit of detection, and may significantly advance early disease diagnostics. Unlike current technology, which attaches a fluorescent molecule, or label, to the antigen to allow it to be seen, the new process detects the antigen without an interfering label.

Stephen Arnold, University Professor of applied physics and member of the Othmer-Jacobs Department of Chemical and Biomolecular Engineering, published details of the achievement in Nano Letters, a publication of the American Chemical Society.

They believe the new limit of detection may be smaller than 0.01 attograms.
This latest milestone builds on a technique pioneered by Arnold and collaborators from NYU-Poly and Fordham University. In 2012, the researchers set the first sizing record by treating a novel biosensor with plasmonic gold nanoreceptors, enhancing the electric field of the sensor and allowing even the smallest shifts in resonant frequency to be detected. Their plan was to design a medical diagnostic device capable of identifying a single virus particle in a point-of-care setting, without the use of special assay preparations.

At the time, the notion of detecting a single protein—phenomenally smaller than a virus—was set forth as the ultimate goal. When the immune system encounters a virus, it generates antibody proteins, and all cancers generate protein markers. A test capable of detecting a single protein would be the most sensitive diagnostic test imaginable.

To the surprise of the researchers, examination of their nanoreceptor under a transmission electron microscope revealed that its gold shell surface was covered with random bumps roughly the size of a protein. Computer mapping and simulations created by Stephen Holler, once Arnold’s student and now assistant professor of physics at Fordham University, showed that these irregularities generate their own highly reactive local sensitivity field.

Arnold and his colleagues posit that the ability to follow a signal in real time—to actually witness the detection of a single disease marker protein and track its movement—may yield new understanding of how proteins attach to antibodies.

The research has been supported by a grant from the National Science Foundation.

Type: Article

NYU-Poly Nanoscientists Reach the Holy Grail in Label-Free Cancer Marker Detection: Single Molecules

Search News

NYU In the News

NYU Received a Record Number of Applications

Capital New York reported NYU received a record 60,322 applications for the class of 2019, an increase of about 15 percent since last year.

NYU Students Help City Crack Down on Hookah Bars

Capital New York reported that NYU students helped New York City crack down on hookah bars that illegally include tobacco in their hookahs:

Rudin Center Study Says Mass Transit Helps Economic Mobility

The Wall Street Journal wrote about a report by Wagner’s Rudin Center that showed that mass transit could be more important than education in determining economic mobility.

Brennan Center Report Says Campaign Spending Has Jumped

Frontline did a piece about a report by the Brennan Center for Justice that said that campaign spending by outside groups has more than doubled in the last five years.

NYU’s Dorms Ranked Among the Best in the Nation ranked NYU’s student residences third in the country in its list of best college dorms.


NYU Footer